Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma × CP protocol × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 1 Ovarian Neoplasms 1 Non-Small Cell Lung Cancer With HER2- Mutations 1 Non Small Cell Lung Carcinoma NSCLC 1 Lung Neoplasms 1

Interventions

pembrolizumab 16 Magnetic Resonance Spectroscopy 13 Specimen Handling 12 Cisplatin 12 Carboplatin 9 Paclitaxel 8 Radiotherapy, Intensity-Modulated 6 Platinum 6 Cetuximab 6 1,2-diaminocyclohexaneplatinum II citrate 6 Biopsy 5 durvalumab 4 Pemetrexed 4 (225)Ac-DOTA-c(RGDyK) 4 osimertinib 3 Taxes 3 Radiotherapy 3 Radiation 3 Immunoglobulin G 3 Gemcitabine 3 Disulfides 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 olaparib 2 ipatasertib 2 cemiplimab 2 cabozantinib 2 Tadalafil 2 Nivolumab 2 Ipilimumab 2 Fluorouracil 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡